1) Chronic alcoholic liver disease
慢性酒精性肝病
2) Alcoholic liver disease
酒精性肝病
1.
Role of Chinese medicine Kangxian Fufang I in the prevention and treatment of alcoholic liver disease and dynamic changes of tissue inhibitor of metalloproteinase-1 in rats;
金属蛋白酶组织抑制剂1在抗纤复方Ⅰ号防治酒精性肝病中的作用
2.
The model establishment of alcoholic liver disease in rats and correlation study with leptin;
大鼠酒精性肝病模型的建立及与瘦素关系的研究
3.
Effect of Chinese medicine KX I on prophylaxis and treatment of alcoholic liver disease in rats and the dynamic change of matrix metalloproteinase;
基质金属蛋白酶在抗纤复方Ⅰ号防治大鼠酒精性肝病中的表达
3) alcoholic liver disease(ALD)
酒精性肝病
1.
[Objective] To investigate the relationship between the hepatocyte apoptosis, CYP2E1, TNF-α and oxygen free radical in alcoholic liver disease(ALD)in rats.
目的探讨大鼠酒精性肝病细胞凋亡与细胞色素P4502E1、TNF-α及氧自由基的关系。
2.
Objective To study the relation of serum leptin and liver function in patients with alcoholic liver disease(ALD).
目的探讨瘦素在酒精性肝病(ALD)及不同阶段中的变化规律及其与肝功能受损的关系。
3.
【Objective】 To observe the pathological changes and investigate the hepatocyte apoptosis relating with Bcl-2 and NF-kB in alcoholic liver disease(ALD)of rats.
目的观察大鼠酒精性肝病组织病理形态学改变,探讨细胞凋亡与Bcl-2、NF-kB的表达及意义。
4) ALD
酒精性肝病
1.
Hepatocyte Apoptosis and Fas-mediated Apoptosis in the Rat Model of ALD;
实验性酒精性肝病肝细胞凋亡及其相关分子表达的研究
2.
Objective: To study the protective effect of saikosaponins(SS) on alcoholic liver disease(ALD) in rats and its mechanism.
目的:研究柴胡总皂苷对大鼠酒精性肝病(ALD)的预防作用及其机制。
5) alcoholic liver diseases
酒精性肝病
1.
Therapeutic effect of GSH on the treatment of alcoholic liver diseases.;
还原型谷胱甘肽治疗酒精性肝病临床疗效观察
6) acute alcololic liver disease
急性酒精性肝病
补充资料：酒精性肝病
酒精性肝病
alcoholic liver disease
由酒精中毒引起肝脏疾病，主要有酒精性脂肪肝、酒精性肝炎及肝硬化。酒精性脂肪肝是因乙醇在肝内代谢为乙醛及乙酸时，辅酶Ⅰ转变为还原辅酶Ⅰ增加，抑制三羧酸循环，肝内脂肪酸合成增多而致脂肪肝。酒精性肝炎为肝细胞肿胀，线粒体变形，胞质中出现乙醇透明小体，肝细胞变性，周围纤维化。严重者可出现小结节性肝硬化。临床常表现为肝肿大，常与病变程度相关，轻者无症状，重者可有肝炎表现。肝硬化者除有一般肝硬化表现外，还有慢性酒精中毒引起的掌挛缩和脑病等表现。无特异性治疗，以高热量平衡饮食、护肝、补充维生素等；肝硬化则同其他肝硬化一样处理。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条